DOCSLIB.ORG

Pharma Times Pharmacist the ‘Apostrophe’ of the Health Profession

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pharma Times Pharmacist the ‘Apostrophe’ of the Health Profession Single Copy Price ` 250 Vol. 52 No. 04 | April 2020 ISSN 0031-6849 Total Pages : 63 Indexed by Scopus & Embase Official Monthly Newsmagazine of Indian Pharmaceutical Association Listed in journals approved by UGC for CAS & Appointment of University Teachers Commitment to Public Health and Science will go a long way in Defeating ‘Pandemics’ ... 22 Pharmaceutical Sector of India, Perspectives & its Journey During Covid-19: Recent Problems & Strategic Solutions –PPP Mode .................................................15 Pharma Times Pharmacist the ‘Apostrophe’ of the Health profession ..... 20 Official Publication of: Covid-19: A Wake up Call for Pharma Stakeholders...........25 The Indian Pharmaceutical Association, Safety of Pharmaceutical Employees in Covid-19 Kalina, Santacruz (E), Mumbai 400098. Pandemic ........................................................................................26 Pharma Times - Vol. 52 - No. 04 - April 2020 PB Pharma Times -- Vol.Vol. 5252 -- No.No. 0304 -- MarchApril 2020 2020 2 44 Pharma Pharma Times Times - Vol.- Vol. 52 52 - No.- No. 03 04 - March- April 20202020 453 COL Pharma Times - Vol. 52 - No. 0403 - AprilMarch 2020 2020 2 2 Pharma Pharma Times Times - Vol.- Vol. 52 52 - No.- No. 03 04 - March- April 2020 3 Contents Novel Coronavirus Pandemic- Stark Realities & New Lessons for Science & Humanity: Dr. Jayant B Dave, Adjunct Professor, L M College of Pharmacy, Ahmedabad .................................................................................9 Pharmaceutical Sector of India, Perspectives & its Journey During Covid-19 : Recent Problems & Strategic Solutions37 –PPP Mode: 42 11 Dr. Dinesh Dua, Chief Executive Officer (CEO) & Whole Time Director, M/S Nectar Lifesciences Ltd. India & Chairman, Pharmexcil, Ministry of Commerce, Govt. of India .....................................................................................................15 Pharmacist the ‘Apostrophe’ of the Health profession Dr B Suresh, President, Pharmacy Council of India, New Delhi Pro Chancellor, JSS Academy of Higher Education and Research, Mysuru .....................................................................................20 Commitment to Public Health and Science will go a 11long way in defeating ‘Pandemics’: 37 42 14 Dr. Krishna Ella,45 Chairman & Managing Director, Bharat53 Biotech ...................................................................................................22 Contents Covid-19: A Wake up Call for Pharma Stakeholders: Lipid Excipients In Pharmaceutical Technologies .................................11 Dr. Ajit Dangi, President & CEO, Danssen Consulting ....................................................................................................................25 Lipidic excipients in drug delivery for solubility and bioavailability enhancement .....................................................................................14 Safety of Pharmaceutical Employees in Covid-19 Pandemic:14 45 53 S. G. Belapure, Senior Technical Advisor, Indian Pharmaceutical56 Alliance ......................................................................................26 From Exploration of Lipids to its Exploitation in Market: 54 Pharmaceuticals, Nutraceuticals and Herbal .......................................20 Contents A snapshot of lipid excipients for Topical Formulations.......................26 Pharmacy Experiences in India in SARS-Cov-2: Lipid ExcipientsRaj In Vaidya, Pharmaceutical Community Technologies Pharmacist, ................................. Hindu Pharmacy, Panaji11 . ........................................................................................................30 Processing technologies from Romaco Innojet GMP compliant Lipidic excipients in drug delivery for solubility and bioavailability hot melt device for applying pharmaceutical coatings .........................29 enhancement .....................................................................................14 Strategic Lipid-Based Delivery Interventions for Enhancing Oral Embracing 4.0 in Pharma Academics: Way Forward: 54 56 From ExplorationDr. Richaof Lipids Dayaramani, to its Exploitation Principal, in Khyati Market: College of Pharmacy ........................................................................................................36 Bioavailability of BCS II/IV Drugs .......................................................37 56 Pharmaceuticals, Nutraceuticals and Herbal .......................................20 Unleashing role of excipients in overcoming formulation challenges ....42 A snapshot ofAn lipid International excipients forCrisis: Topical Long Formulations Term Impact....................... of Covid-19 Pandemic26 on Health Care Scenario, Role of lipid excipients in oral sustained release drug delivery systems ..45 Pharma Times ProcessingOfficial technologiesWorldwide Publication fromPharmaceutical ofRomaco The Indian Innojet Growth Pharmaceutical GMP and compliant Global Association Economy: hot melt deviceAnil for Kharia applying*, Sapna pharmaceutical Malviya1, Ankur coatings Joshi .........................1, 29 Indexed by Scopus & Embase Regular Features Strategic Lipid-Based*President, Delivery IPA MP Interventions State Branch, for EnhancingIndore, 1Indian Oral Pharmaceutical Association, MP State Branch, Indore .....................................39 From the Editor’s Desk ............................................................................5 EDITOR Dr. B. Suresh Dr. N. Shivaprasad BioavailabilityDr. Alka Mukne of BCS II/IVDr. Drugs C. Gopalakrishna ....................................................... Murty Dr. P. Khadgapathi 37 56 President Speak ......................................................................................7 EDITORIAL ASSISTANTS Dr. J. A. S. Giri Dr. Premnath Shenoy UnleashingArjun Jeswani role of excipientsKaushik in overcoming Desai formulationPuneet challenges Gupta ....42 Guest Editorial ......................................................................................8,9 Regular FeaturesDr. Mukund Yelvigi Neha Dabholkar Dr. P.N. Murthy Role of lipid excipients in oralPrafull sustained Sheth release drug delivery systems ..45 Pharma Times Advertisement Tariff .............................................................................13 Pooja Kulthe Raj Vaidya FromRasika The R. Dharap Editor’s Desk ........................................................................Dr. Rao V.S.V. Vadlamudi 5 Official Publication of The Indian Pharmaceutical Association Book Review .........................................................................................25 Shashikant Joag Rajesh Bhandari Rishab Babel Dr. R.N. Gupta Indexed by Scopus & Embase PresidentRegularSaee H. Misal Speak ................................................................................... FeaturesSubodh Priolkar 7 Letter to Editor ......................................................................................28 Sanjay Jain FromSakshi the Y. KasatEditor’s Desk ............................................................................EDITORIAL BOARD 5 EDITOR Dr. B. Suresh Dr. N. Shivaprasad Announcement ......................................................................30,41,55,57 "IPASeline in Dantes the News!!" ............................................................................Dr B.N. Sinha Dr. Shailendra Saraf 8 Dr. Alka Mukne Dr. C. Gopalakrishna Murty Dr. P. Khadgapathi PresidentShweta S.Shinde Speak ......................................................................................Dr. Divakar Goli Shyamal Kalani 7 EDITORIAL ASSISTANTS Dr. J. A. S. Giri Dr. Premnath Shenoy Kaushik Desai IPA Building Progress Report .................................................................31 Tamanna Gidwani Hemanta Kr. Sharma Sripati Singh Arjun Jeswani Puneet Gupta ObituryGuest Editorial ......................................................................................... ......................................................................................14,218,9 Dr. Mukund Yelvigi Vibhusha Dube Dr. Subhash Mandal Neha Dabholkar Dr. P.N. Murthy Pharmexcil Updates ...............................................................................44 Dr. Jayant Dave Prafull Sheth LetterAdvertisementADVISORY To Editor BOA TariffRD ................................................................................. .............................................................................Kalhan Bazaz Dr. S.P. Manek 1333 Pooja Kulthe Raj Vaidya Advertisement Index ..............................................................................47 Rasika R. Dharap Dr. Rao V.S.V. Vadlamudi BookDr. A. Review I. Mehta ......................................................................................... M.P. George Prof. T.V. Narayana 25 Shashikant Joag Rajesh Bhandari Advertisement Tariff ..........................................................................42 Rishab Babel Dr. R.N. Gupta Minutes of CEC Meeting .......................................................................48 Copyright of Indian Pharmaceutical Association. All rights reserved throughout the world. Saee H. Misal Subodh Priolkar Letter to Editor ......................................................................................28 Sanjay Jain Campus News .......................................................................................53 Reproduction in any manner is prohibited. Sakshi Y. Kasat EDITORIAL BOARD AdvertisementAnnouncement Index.....................................................................
Load more

Recommended publications
  • 53Rd AIIMS ANNUAL REPORT 2008–2009
    53rd AIIMS ANNUAL REPORT 2008–2009 All India Institute of Medical Sciences New Delhi 110029 Edited jointly by: Dr Sunil Chumber, Additional Professor, Department of Surgical Disciplines and Sub-Dean (Academic) Dr Tanuj Dada, Associate Professor, Dr R.P. Centre for Ophthalmic Sciences Dr Venkata Karthikeyan C, Assistant Professor, Department of Otorhinolaryngology (ENT) Dr S.K. Maulik, Professor, Department of Pharmacology Dr Raj D. Mehra, Professor, Department of Anatomy Dr Kameshwar Prasad, Professor, Department of Neurology Dr S. Rastogi, Professor, Department of Orthopaedics Dr Sushma Sagar, Assistant Professor, JPNA Trauma Centre Dr Peush Sahni, Professor, Department of Gastrointestinal Surgery Dr Pratap Sharan, Professor, Department of Psychiatry Dr D.N. Sharma, Assistant Professor, Dr BRA, Institute Rotary Cancer Hospital Dr Subrata Sinha, Professor and Head, Department of Biochemistry Dr Sanjay Kumar Sood, Assistant Professor, Department of Physiology Dr Sachin Talwar, Assistant Professor, Department of C.T.V.S. February 2010 Printed at Saurabh Printers Pvt. Ltd., A-16, Sector-IV, NOIDA (U.P.) All India Institute of Medical Sciences The All India Institute of Medical Sciences (AIIMS) was established in 1956 as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education to all medical colleges and other allied institutions in India; to bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity and to attain self-sufficiency in postgraduate medical education.
    [Show full text]
  • Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
    CLASSIFICATION DECISIONS TAKEN BY THE HARMONIZED SYSTEM COMMITTEE FROM THE 47TH TO 60TH SESSIONS (2011 - 2018) WORLD CUSTOMS ORGANIZATION Rue du Marché 30 B-1210 Brussels Belgium November 2011 Copyright © 2011 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to [email protected]. D/2011/0448/25 The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee ( 47th Session – March 2011) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale. Advice Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be. HS codes Classification No Product description Classification considered rationale 1. Preparation, in the form of a powder, consisting of 92 % sugar, 6 % 2106.90 GRIs 1 and 6 black currant powder, anticaking agent, citric acid and black currant flavouring, put up for retail sale in 32-gram sachets, intended to be consumed as a beverage after mixing with hot water. 2. Vanutide cridificar (INN List 100). 3002.20 3. Certain INN products. Chapters 28, 29 (See “INN List 101” at the end of this publication.) and 30 4. Certain INN products. Chapters 13, 29 (See “INN List 102” at the end of this publication.) and 30 5. Certain INN products. Chapters 28, 29, (See “INN List 103” at the end of this publication.) 30, 35 and 39 6. Re-classification of INN products.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • WHO Drug Information
    WHO DRUG INFORMATION VOLUME 8 - N U M B E R 3 1994 RECOMMENDED INN LIST 34 INTERNATIONAL NONPROPRIETARY N A M E S F O R P H A R M A C E U T I C A L SUBSTANCES WORLD HEALTH ORGANIZATION • GENEVA Volume 8, Number 3, 1994 World Health Organization, Geneva WHO Drug Information Contents General Policy Topics Regulatory Matters Ethics and drug promotion: the CIOMS Large-scale HIV vaccine trials deferred 152 consensus 123 Antidepressants and hyponatraemia 152 Azapropazone and photosensitivity 153 Personal Perspectives Blood: safeguards to prevent Revision of the IFPMA code of pharmaceutical transmission of pathogens 153 Bromocriptine: no longer recommended to marketing practices 125 suppress lactation 153 Counterfeit medicines: a growing concern 154 Update on AIDS Felbamate and aplastic anaemia 154 HIV vaccines: advances and setbacks 128 Neuroleptic sensitivity in dementia 155 Zidovudine: redressment of early expectations 130 Nonsteroidal anti-inflammatory drugs: Zidovudine: renewed encouragement 131 relative safety 155 China to work with the European Reports on Individual Drugs Pharmacopoeia Commission 156 Antiarrhythmic agents: more concerns over Move to ban distribution of drug samples 156 risks and benefits 134 Theophylline potentiated by fluvoxamine 156 Oral contraceptives: no apparent association Tiaprofenic acid and severe cystitis 156 with diabetic complications 135 Zidovudine approved to prevent HIV Oral contraceptive use and protection against transmission in pregnancy 157 ovarian cancer 136 Ethical criteria for medicinal drug promotion
    [Show full text]
  • National Expert Group Technical Consultation on Prevention and Treatment of Iron Deficiency Anemia H.P.S
    INDIAN JOURNAL OF COMMUNITY HEALTH / VOL 30 / SUPP ISSUE / APR 2018 [National expert group…] | H.P.S. Sachdev et al RECOMMENDATIONS National expert group technical consultation on prevention and treatment of iron deficiency anemia H.P.S. Sachdev1, Anura Kurpad2, Renu Saxena3 , Umesh Kapil4 1Senior Consultant Pediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science and Research, B-16 Qutab Institutional Area, New Delhi 110016; 2Professor of Physiology and Nutrition, St John’s Medical College, Sarjapur Raod, Bengaluru 560034, Karnataka; 3Professor and Head, Department of Hematology, All India Institute of Medical Sciences, New Delhi; 4Professor Public Health Nutrition, Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi. Abstract Introduction Methodology Results Conclusion References Citation Tables / Figures Corresponding Author Address for Correspondence: H.P.S. Sachdev, Senior Consultant Pediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science and Research, B-16 Qutab Institutional Area, New Delhi 110016. E Mail ID: [email protected] Citation Sachdev HPS, Kurpad A, Saxena R, Kapil U. National expert group technical consultation on prevention and treatment of iron deficiency anemia. Indian J Comm Health. 2018; 30, Supp: I-XI. Source of Funding: Nil Conflict of Interest: None declared This work is licensed under a Creative Commons Attribution 4.0 International License. Recommendations A “National Expert Group Technical Consultation on Prevention and Treatment of Iron Deficiency
    [Show full text]
  • ( 12 ) United States Patent
    US010131766B2 (12 ) United States Patent (10 ) Patent No. : US 10 , 131, 766 B2 Hazen et al. (45 ) Date of Patent: Nov . 20 , 2018 ( 54 ) UNSATURATED POLYESTER RESIN 6 ,619 ,886 B1 9 /2003 Harrington 6 ,692 , 802 B1 2 / 2004 Nava SYSTEM FOR CURED IN - PLACE PIPING 7 , 135 ,087 B2 11/ 2006 Blackmore et al. 7 ,799 ,228 B2 9 /2010 Bomak et al . (71 ) Applicant : Interplastic Corporation , Saint Paul, 8 , 047, 238 B2 11/ 2011 Wiessner et al . MN (US ) 8 ,053 ,031 B2 11/ 2011 Stanley et al. 8 ,092 ,689 B2 1 / 2012 Gosselin (72 ) Inventors : Benjamin R . Hazen , Roseville , MN 8 , 298 , 360 B2 10 / 2012 Da Silveira et al. 8 ,418 , 728 B1 4 / 2013 Kiest , Jr . (US ) ; David J . Herzog , Maple Grove , 8 ,586 ,653 B2 11 / 2013 Klopsch et al. MN (US ) ; Louis R . Ross, Cincinnati , 8 ,636 , 869 B2 1 / 2014 Wiessner et al . OH (US ) ; Joel R . Weber , Moundsview , 8 ,741 , 988 B2 6 /2014 Klopsch et al. MN (US ) 8 , 877 , 837 B2 11/ 2014 Yu et al. 9 ,068 , 045 B2 6 /2015 Nava et al. 9 ,074 , 040 B2 7 / 2015 Turshani et al. ( 73 ) Assignee : Interplastic Corporation , St. Paul , MN 9 , 150 , 709 B2 10 / 2015 Klopsch et al . (US ) 9 , 207 , 155 B1 12 / 2015 Allouche et al. 9 ,273 ,815 B2 3 / 2016 Gillanders et al. ( * ) Notice : Subject to any disclaimer, the term of this 9 , 371, 950 B2 6 / 2016 Hairston et al. patent is extended or adjusted under 35 9 , 550 , 933 B2 1 /2017 Chatterji et al .
    [Show full text]
  • Report 109 Commttee on Health and Family Welfare
    REPORT NO. 109 PARLIAMENT OF INDIA RAJYA SABHA DEPARTMENT-RELATED PARLIAMENTARY STANDING COMMITTEE ON HEALTH AND FAMILY WELFARE ONE HUNDRED NINTH REPORT The National Medical Commission Bill, 2017 (Presented to the Rajya Sabha on20 th March, 2018 ) (Laid on the Table of Lok Sabha on20 th March, 2018 ) Rajya Sabha Secretariat, New Delhi March, 2018/Phalguna, 1939 (Saka) Website : http://rajyasabha.nic.in E-mail : [email protected] 117 Hindi version of this publication is also available PARLIAMENT OF INDIA RAJYA SABHA DEPARTMENT-RELATED PARLIAMENTARY STANDING COMMITTEE ON HEALTH AND FAMILY WELFARE ONE HUNDRED NINTH REPORT The National Medical Commission Bill, 2017 (Presented to the Rajya Sabha on 20th March, 2018) (Laid on the Table of Lok Sabha on 20th March, 2018) Rajya Sabha Secretariat, New Delhi March, 2018/ Phalguna, 1939 (Saka) CONTENTS PAGES 1. COMPOSITION OF THE COMMITTEE ....................................................................................... (i)-(ii) 2. INTRODUCTION ...................................................................................................................... (iii)-(iv) 3. ACRONYMS ............................................................................................................................ (v)-(vii) 4. REPORT ................................................................................................................................. 1-67 5. RECOMMENDATIONS/OBSERVATIONS — AT A GLANCE .......................................................... 68-82 6. MINUTES ..............................................................................................................................
    [Show full text]
  • Supplement - 2013
    IJPPAZ 57 (5) (2013) ISSN 0019-5499 Volume 57 - Number 5 - Supplement - 2013 Indian Journal of Physiology and Pharmacology The official Journal of the Association of Physiologists and Pharmacologists of India 59th Annual Conference of Association and Physiologists of India, APPICON-2013, i 28-30, November 2013 organized at NIMHANS, Bengaluru – 560 029 ii 59th Annual Conference of Association and Physiologists of India, APPICON-2013, 28-30, November 2013 organized at NIMHANS, Bengaluru – 560 029 Preface It is our immense pleasure to invite you to National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru forthe 59thAnnual Conference of Association of Physiologists and Pharmacologists of India (APPI). During the conference, we aim the globe..The theme of the conference is Decades of Research in Physiology and Pharmacology:to discuss the scientific Reminders advances to remember achieved and in focus. Physiology and Pharmacology across an opportunity for the delegates to keep themselves abreast with the rapid progress Scientific program including plenary lectures and symposia is being planned to provide heartening that several leading scientists have consented to participate in these academic exercises.being made In inaddition the exciting to the fields usual of CME physiology program, and three pharmacology. pre-conference In this workshops regard, itare is being planned to provide a more interactive and hands on training opportunity. Bengaluru is an enchanting city in which the old world charm of its cultural heritage blends with the excitement of technological boom. The city is considered to be the activities. We welcome you to experience the science city of Bengaluru. WishingNational youcenter all a of pleasant scientific stay information at Bengaluru – technological, industrial and educational Dr.
    [Show full text]
  • Pharmaceutical Appendix to the Harmonized Tariff Schedule
    Harmonized Tariff Schedule of the United States Basic Revision 3 (2021) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States Basic Revision 3 (2021) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • NEET-PG-2017-Question-Paper-With
    Anatomy Question 1 Identify the type of muscle shown in the image below. A> Cruciate B> Multipennate C> Parallel D> Unipennate Answer - B. Multipennate Explanation - Pectoralis Major has multiple rows of diagonal fibres with a single tendon, Hence is a multipennate muscle. Question 2 Nerves of Branchial arch derived from: A> Mesoderm B> Endoderm C> Neural crest D> Neuroectoderm Answer - C Explanation - Branchial or pharyngeal arches are masses of mesoderm covered by ectoderm and lined by endoderm. Within these masses, muscular and skeletal components develop, as well as aortic arches and nerve networks. The arches are separated by grooves, visible on the surface of the embryo as pharyngeal clefts and in the interior as the pharyngeal pouches ● In the human embryo, the arches are first seen during the 4th week of development. ● They appear as a series of outpouchings of mesoderm on both sides of developing pharynx. The neural crest are bilaterally paired strips of cells arising in the ectoderm at the margins of the neural tube. These cells migrate to many different locations and differentiate into many cell types within the embryo. Neural Crest Derivatives A key feature of neural crest is the migration into other embryonic tissues to form specific neural and non- neural populations and structures. Cranial neural crest ● migration - dorsolaterally and into pharyngeal arches ● craniofacial mesenchyme - cartilage, bone, cranial neurons, glia, and connective tissues of the face ● pharyngeal arches and pouches - thymic cells, tooth odontoblasts, middle ear bones (ossicles), stria vascularis cells, and jaw (mandible) In the body region, neural crest cells also contribute the peripheral nervous system (both neurons and glia) consisting of sensory ganglia (dorsal root ganglia), sympathetic and parasympathetic ganglia and neural plexuses within specific tissues/organs.
    [Show full text]
  • List of Candidates for Consideration to Membership of the Academy Who Passed the Diplomate of National Board of Examinations
    List of Candidates for consideration to Membership of the Academy who Passed the Diplomate of National Board of Examinations S.No. Name & Address of Candidate Roll Number/Year of Passing/ Name of Proposer Speciality 1. Dr. Indhu Kannan 1623321228/Dec.2016/ Dr. R. Rathinam, FAMS 11-1/306, Madurai Theni Road, December, 2016 Madurai Palaniammal Childrens Hospital, Pathology Andipatti, Theni, Tamil Nadu-625512. 2. Dr. Karthikeyan V S 1622402022/Dec.2016/ Dr. R. Rathinam, FAMS Palaniammal Children’s Hospital, December, 2016 Madurai No.11-1/306, Madurai Theni Road, Radiodiagnosis Aundipatty – 625512, Theni Road, (Tamil Nadu). 3. Dr. Manujesh Bandyopadhyay 1521041047/Dec.2015/ Dr. Saibal Gupta, FAMS Mainadanga (West), December, 2015 Kolkata Chinsurah, Hooghly – 712102, Cardio Thoracic Surgery West Bengal. 4. Dr. Rashmi Tiwari 1613391052/June, 2016/ Dr. Rashmi Kumar, FAMS 160 Income Tax Housing Society, June, 2016 Lucknow Vinayak Pur, Psychiatry Kanpur – 208024. 5. Dr. N Vasanthi Med/71/159/June/2007/ Dr. Ashok Kumar Das, Department of General Medicine, October, 2007 FAMS ‘E’ Quarters, 3rd Floor, General Medicine Pondicherry Pondicherry Institute of Medical Sciences, Kalapet, Kanagachetti Kulam Puducherry – 605014. 6. Dr. Tim Thomas Joseph 0452 Dr. M. V. S. Valiathan, QTS No.106, KMC Campus, December, 2012 FAMS Manipal – 576104. Anaesthesiology Manipal 7. Dr. Unnikuttan D 1621271029/Dec. 2016/ Dr. Aleyamma Mathew, Puthumana, December, 2016 FAMS Puthiyavila P.O., Orthopaedics Thiruvanthanpuram Alappuzha (D), Kerala – 690531. 8. Dr. Hena Rani - Dr. A.C. Anand, FAMS A-4/147, Paschim Vihar, July, 2008 New Delhi New Delhi – 110063. Microbiology 9. Dr. Nandan Kumar Mishra 1623271169/Dec.2016/ Dr. Urmila Thatte, FAMS House No.303, Block No.13, Sector 1, December, 2016 Mumbai Khelgaon Housing Complex, Orthopaedics PO – Hotwar, Ranchi, Jharkhand – 835217.
    [Show full text]
  • Providing for Duty-Free Treatment for Specified Pharmaceutical Active
    13 . 3 . 97 I EN I Official Journal of the European Communities No L 71 / 1 I (Acts whose publication is obligatory) COUNCIL REGULATION (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical THE COUNCIL OF THE EUROPEAN UNION , whereas in the context of the review it was concluded that it was appropriate to rectify the situation with regard Having regard to the Treaty establishing the European to certain INNs whose use was predominantly non­ Community, and in particular Article 113 thereof, pharmaceutical and which had been inadvertently included among those INNs already receiving duty-free treatment, Having regard to the proposal from the Commission , Whereas, in the course of the Uruguay Round negotia­ HAS ADOPTED THIS REGULATION : tions the Community and a number of countries discussed duty-free treatment of pharmaceutical products ; Article 1 Whereas the participants in those discussions concluded that in addition to products falling within the Harm­ From 1 April 1997 the Community shall also accord onized System (HS) Chapter 30 and HS headings 2936 , duty-free treatment for the INNs listed in Annex I as well 2937, 2939 and 2941 , duty-free treatment should be given as the salts, esters and hydrates of such products . to designated pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the Article 2 World Health Organization as well as specified salts , esters and hydrates of such INNs, and also to designated From 1 April 1997 the Community shall also grant duty­ products used for the production and manufacture of free treatment for the products used in the production finished products ; and manufacture of pharmaceutical products listed in Annex II .
    [Show full text]